The future of medicine
begins with a root.
Equatoria Biosciences cultivates and supplies the world's highest-grade Tabernanthe iboga root bark — the singular source of ibogaine — to researchers advancing the next generation of neurological and addiction medicine.
One of the largest premium iboga plantations on Earth. Ours, exclusively, for half a century.
Equatoria holds a 50-year exclusive cultivation and export agreement on a 30-hectare estate deep in the equatorial rainforest belt of Gabon — the ancestral homeland of Tabernanthe iboga. The volcanic soil, rainforest microclimate, and traditional cultivation methods produce root bark of an alkaloid concentration and purity unmatched anywhere else.
No other commercial entity has continuous, large-scale, legal access to iboga of this provenance and grade. Every shipment is traceable to a parcel, a harvest, and a hand.
- 50-year exclusive cultivation & export agreement
- 30 hectares under active organic cultivation
- Capacity to export up to 1,000 kg of root monthly
- Single-origin chain of custody, parcel-level traceability
A bridge between ancient pharmacognosy and modern frontier medicine.
For centuries, the iboga plant of equatorial Africa has been revered for its extraordinary properties. Today, the alkaloids extracted from its root bark — chiefly ibogaine — are being investigated by the world's leading neuroscientists for their potential to interrupt opioid addiction, treat PTSD, and repair neurological pathways.
Equatoria Biosciences exists to make that research possible. We operate as the ethical supply backbone connecting a singular African origin to the laboratories defining what comes next in medicine.
Rooted in Gabon
Cultivated on a 30-hectare plantation under our exclusive 50-year right — the species' native ecosystem.
Built with the land
Traditional, organic cultivation practices alongside Gabonese horticulturists and the local community.
Institutional supply
We work with licensed research institutions advancing peer-reviewed iboga and ibogaine science.
A molecule rewriting the rules of neurological medicine.
From Stanford to São Paulo, peer-reviewed studies are investigating ibogaine and its derivatives as potential breakthrough therapies for opioid-use disorder, traumatic brain injury, depression, and PTSD.
Ready to advance your research?
We work with licensed research institutions. Reach out to discuss supply, documentation, and timelines for your program.
Contact Equatoria